Suppr超能文献

在辅助生殖项目中使用顶体反应对离子载体激发试验来管理患者:一项前瞻性、双盲、随机对照研究。

Use of the acrosome reaction to ionophore challenge test in managing patients in an assisted reproduction program: a prospective, double-blind, randomized controlled study.

作者信息

Yovich J M, Edirisinghe W R, Yovich J L

机构信息

PIVET Medical Centre, Perth, Western Australia.

出版信息

Fertil Steril. 1994 May;61(5):902-10. doi: 10.1016/s0015-0282(16)56704-1.

Abstract

OBJECTIVE

To assess the utility of the acrosome reaction (AR) to ionophore challenge test in determining the sperm treatment protocols for patients undergoing assisted reproduction.

DESIGN, SETTING, PATIENTS: One hundred twenty-one couples undergoing an IVF-ET or GIFT procedure from January to July 1992 were included in this prospective study. All cases had a preliminary semen analysis within the previous 3 months and an AR to ionophore challenge test was carried out unless an acceptable fertilization rate occurred on previous IVF. For those patients whose AR to ionophore challenge score was below the accepted fertile range of > or = 10%, a second AR to ionophore challenge test was performed after exposure of sperm to the stimulant pentoxifylline. Couples then were managed by assisted reproduction with randomized allocation of oocytes for fertilization with a standard sperm preparation or with added sperm stimulants, either 3.6 mM pentoxifylline alone or combined with 3.0 mM 2-deoxyadenosine. The study was double-blind with neither the patients nor the embryologist knowing the AR to ionophore challenge result at the time of the IVF procedure.

MAIN OUTCOME MEASURES

Data from the preliminary semen analyses and AR to ionophore challenge scores were correlated with the fertilization rates achieved using control and treated sperm preparations. The rates of total fertilization failure and the numbers of clinical pregnancies occurring in each subgroup were also recorded.

RESULTS

All AR to ionophore challenge groups showed normal sperm counts except the groups with poor AR to ionophore challenge, which demonstrated reduced sperm counts. The group with normal AR to ionophore challenge scores or previous normal fertilization showed satisfactory fertilization rates with either control or treated sperm, although some individual cases showed reduced fertilization with treated sperm. The fertilization rate for the group with low AR to ionophore challenge scores improved significantly with pentoxifylline, and the benefit was greatest when this had been predicted from the AR to ionophore challenge studies. Cases with persisting poor AR to ionophore challenge despite pentoxifylline showed no significant improvement in fertilization rates with sperm exposed to either sperm stimulant regimens. Poor AR to ionophore challenge scores were also predictive of total fertilization failure, but this problem was reduced by sperm stimulation. The AR to ionophore challenge score at 10% cutoff level showed optimal levels of sensitivity (82.1%), highest negative predictive value (82.1%), and lowest false negative rate (17.9%).

CONCLUSIONS

The AR to ionophore challenge test is useful in the assessment and management of the male factor in assisted reproduction. It can be used to identify the majority of cases who will benefit from the use of sperm stimulants.

摘要

目的

评估顶体反应(AR)对离子载体激发试验在确定接受辅助生殖患者的精子处理方案中的效用。

设计、地点、患者:1992年1月至7月接受体外受精-胚胎移植(IVF-ET)或配子输卵管内移植(GIFT)手术的121对夫妇纳入了这项前瞻性研究。所有病例在之前3个月内进行了初步精液分析,除非之前IVF时有可接受的受精率,否则均进行AR对离子载体激发试验。对于那些AR对离子载体激发试验评分低于公认的>或=10%的可育范围的患者,在精子暴露于兴奋剂己酮可可碱后进行第二次AR对离子载体激发试验。然后,夫妇们接受辅助生殖治疗,随机分配卵母细胞,分别用标准精子制备方法或添加精子兴奋剂(单独使用3.6 mM己酮可可碱或与3.0 mM 2-脱氧腺苷联合使用)进行受精。该研究为双盲研究,患者和胚胎学家在IVF手术时均不知道AR对离子载体激发试验结果。

主要观察指标

初步精液分析数据和AR对离子载体激发试验评分与使用对照和处理后的精子制备方法所达到的受精率相关。还记录了每个亚组中完全受精失败的发生率和临床妊娠的数量。

结果

除了AR对离子载体激发试验较差的组精子计数降低外,所有AR对离子载体激发试验组的精子计数均正常。AR对离子载体激发试验评分正常或之前受精正常的组,使用对照或处理后的精子均显示出令人满意的受精率,尽管个别病例使用处理后的精子受精率降低。AR对离子载体激发试验评分低的组,使用己酮可可碱后受精率显著提高,并且当这是根据AR对离子载体激发试验研究预测时,获益最大。尽管使用了己酮可可碱但AR对离子载体激发试验仍持续较差的病例,暴露于任何一种精子刺激方案的精子受精率均无显著改善。AR对离子载体激发试验评分低也可预测完全受精失败,但通过精子刺激可减少这一问题。AR对离子载体激发试验评分在10%临界值时显示出最佳的敏感性水平(82.1%)、最高的阴性预测值(82.1%)和最低的假阴性率(17.9%)。

结论

AR对离子载体激发试验在辅助生殖中男性因素的评估和管理中是有用的。它可用于识别大多数将从使用精子兴奋剂中获益的病例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验